Mbd6 Gene Methyl Cpg Binding Domain Protein 6 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| MBD6 | |
|---|---|
| Full Name | Methyl-CpG Binding Domain Protein 6 |
| Category | Gene |
| Path | /genes/mbd6 |
| Chromosome | 12q24.31 |
| NCBI Gene ID | 79745 |
| Ensembl ID | ENSG00000166206 |
| UniProt ID | Q9Y5W5 |
| Protein Class | Epigenetic regulator |
MBD6 (Methyl-CpG Binding Domain Protein 6) is a member of the Methyl-CpG Binding Domain (MBD) family of proteins that function as readers of DNA methylation marks. Unlike other MBD family members such as MeCP2, MBD1, and MBD2, MBD6 has been relatively understudied, and its functions are still being elucidated. MBD6 is primarily involved in transcriptional regulation through chromatin-mediated mechanisms and may play roles in cellular processes relevant to neurodevelopment and neurodegeneration.
The MBD family proteins recognize methylated CpG dinucleotides in DNA and recruit chromatin-modifying complexes to regulate gene expression. MBD6, along with MBD5 and MBD11, represents a distinct subgroup within the MBD family characterized by structural features that distinguish them from the classic MBD proteins.
The MBD6 gene is located on chromosome 12q24.31 and consists of approximately 15 exons spanning around 25 kb of genomic DNA. The protein编码 sequence produces a 677-amino acid protein with a molecular weight of approximately 74 kDa.
MBD6 is conserved among vertebrates but shows lineage-specific expansions in some species. The protein contains:
MBD6 contains several functional domains:
MBD6 functions primarily as a transcriptional modulator:
As an epigenetic reader protein, MBD6:
MBD6 involvement in cellular processes includes:
MBD6 is expressed in various tissues:
In the brain, MBD6 is expressed in:
While direct disease associations for MBD6 are limited, emerging research suggests potential roles in neurodegeneration:
MBD6 has been implicated in cancer biology:
Targeting epigenetic regulators including MBD6 offers therapeutic potential:
MBD6 as a research target:
MBD6 interacts with several proteins:
MBD6 participates in pathways including:
The study of Mbd6 Gene Methyl Cpg Binding Domain Protein 6 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.